B Cell Responses in COVID-19

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: COVID 19

Study type: Observational

Funder types: Other

Identifiers

NCT06891170

RC_08072721

Details and patient eligibility

About

In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.

Enrollment: 4 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age >18 at time of signing informed consent form
• Signed informed consent form

Exclusion criteria

• Ongoing drug abuse
• Active or history of neoplastic malignancy
• Active autoimmune disease ongoing treatment with immunosuppressive therapy
• Ischemic heart disease
• Evidence of positive HIV, HCV, HBV test
• Diabetes
• Failure to sign informed consent form

Trial design

4 participants in 1 patient group

Vaccinated or recovered subjects from COVID-19